
'A great honor': Japanese Nobel winners fondly recall award ceremony
“It was a great honor,” said Shimon Sakaguchi, one of the three winners of the Nobel Prize in Physiology or Medicine.
The Japan TimesJapanese scientists Shimon Sakaguchi and Susumu Kitagawa received the 2025 Nobel Prizes in Physiology or Medicine and Chemistry, respectively, at the award ceremony in Stockholm on Wednesday evening.
https://www.japantimes.co.jp/news/2025/12/11/japan/nobel-prize-ceremony-japanese-winners/?utm_medium=Social&utm_source=mastodon #japan #awards #nobelprize #shimonsakaguchi #susumukitagawa
Japanese scientists Sakaguchi and Kitagawa receive Nobel Prizes
The total number of Japanese-born Nobel laureates, including those with U.S. nationality, is now 30.
The Japan TimesJapanese researcher Shimon Sakaguchi, one of the three winners of this year's Nobel Prize in physiology or medicine, has voiced hope to develop effective cancer immunotherapy using regulatory T cells he discovered.
https://www.japantimes.co.jp/news/2025/12/10/japan/nobel-winner-shimon-sakaguchi/?utm_medium=Social&utm_source=mastodon #japan #shimonsakaguchi #nobelprize #cancer #medicine
Nobel winner Shimon Sakaguchi aims for effective cancer treatment
The University of Osaka professor has established startup RegCell in the United States to develop a therapy using regulatory T cells.
The Japan TimesKyoto University professor Susumu Kitagawa, one of the three co-winners of this year’s Nobel Prize in chemistry, has called for long-term financial support for basic research, which takes time to product results.
https://www.japantimes.co.jp/news/2025/12/08/japan/science-health/japan-nobel-winners-speech-in-sweden/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #nobelprize #susumukitagawa #shimonsakaguchi
Nobel co-winner Susumu Kitagawa calls for funds for basic research
It takes around 25 years for basic research to produce results and put them to practical use, says the Kyoto University professor.
The Japan Times
Nobel winner Sakaguchi stresses importance of medical science
Developing new treatments takes time, but he remains optimistic that his work will someday help those with various cancers and other health issues.
The Japan Times
<i>Hagoita</i> paddles depicting newsmakers of 2025 unveiled
Wooden paddles featuring Shohei Ohtani, Prime Minister Sanae Takaichi and 10 others were unveiled by Tokyo-based doll-maker Kyugetsu on Wednesday.
The Japan TimesA Japanese research team that includes 2025 Nobel Prize laureate Shimon Sakaguchi has developed a technique to produce regulatory T cells that suppress excessive immune activity.
https://www.japantimes.co.jp/news/2025/10/29/japan/science-health/nobel-team-cells/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #shimonsakaguchi #medicine #nobelprize
Nobel winner's team develops tech to make regulatory T cells
The team succeeded in turning T cells from mice suffering autoimmune diseases into stable regulatory T cells with a special culture method.
The Japan Times
O Nobel de Medicina e sua implicações para a saúde ocular
As descobertas premiadas podem ajudar a descobrir formas de restaurar o equilíbrio da resposta inflamatória e maneiras de atuar na FOXP3 e nos linfócitos regulatórios para reverter as manifestações de tantas doenças autoimunes que afetam os olhos
Jornal da USP
Japanese Nobel winners attend reception in Tokyo
It was the first time Shimon Sakaguchi and Susumu Kitagawa had appeared together in public since being named Nobel laureates last week.
The Japan TimesShimon Sakaguchi, an immunologist who won this year’s Nobel Prize in physiology or medicine, is calling for a diverse investment in basic scientific research with the knowledge that some projects won’t yield results.
https://www.japantimes.co.jp/news/2025/10/08/japan/science-health/nobel-laureate-sakaguchi-interview/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #shimonsakaguchi #medicine #nobelprize #universityofosaka
Nobel laureate Sakaguchi urges support for science despite its 'poor success rate'
The Nobel Prize winner engaged in research once considered dodgy or even dangerous, and he said he struggled to gain support for it early in his career.
The Japan Times